The Utility of Maternal Blood S100B in Women with Suspected or Established Preeclampsia—A Systematic Review
Biomolecules · 2025
DOI: 10.3390/biom15060840 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Biomolecules, 2025. Verfasst von Grigorios Karampas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Obstetrics and Gynaecology, Aretaieio University Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece. Hauptthemen laut MEDLINE: Pre-Eclampsia, S100 Calcium Binding Protein beta Subunit. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Preeclampsia is a serious pregnancy complication without curative treatment. The central nervous system (CNS) is affected in severe cases of preeclampsia. Until now, no biomarker or other predictive method has been established for predicting severe CNS injury, including the development of eclampsia and/or long-term complications. In this systematic review, we aimed to investigate the association between maternal blood (serum or plasma) S100B levels and preeclampsia, focusing on its predictive value and correlation with the severity of the disease, with a particular focus on neurological symptoms.
Methods
A search of online databases, including Medline via PubMed, Scopus databases, and Web of Science, was performed based on the PRISMA guidelines for systematic reviews.
Results
Ten case–control studies that met the inclusion criteria were identified and further evaluated according to the Newcastle–Ottawa Scale (NOS). All of the studies revealed that S100B blood levels were higher in preeclampsia compared to uncomplicated pregnancies before onset, after its diagnosis, and one year postpartum. Its predictive value seems to be adequate long before the onset of preeclampsia, especially in the early third trimester. Furthermore, its levels seem to correlate with severe complications during pregnancy, such as eclampsia and HELLP syndrome, as well as neurological dysfunction postpartum.
Conclusions
S100B is a promising biomarker for the prediction of acute and long-term CNS injury in preeclampsia. Still, additional studies should be conducted in order to establish a standard method of measurement and solidify its clinical use in preeclampsia management, providing individualized care in order to improve perinatal outcomes and provide personalized follow-up postpartum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Second Department of Obstetrics and Gynaecology, Aretaieio University Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece.
- Division of Obstetrics and Gynecology, Institute of Clinical Sciences Lund, Lund University, 22185 Lund, Sweden.
- Department of Obstetrics and Gynecology, Skåne University Hospital, 20502 Malmö, Sweden.
- Department of Midwifery, School of Health and Care Sciences, University of West Attica, 12243 Athens, Greece.
ORCID-Profile: Grigorios Karampas, Dimitra Metallinou, Lena Erlandsson, Nikolaos Vlahos, Stefan Rocco Hansson, Makarios Eleftheriades
Zitieren
APA
Karampas, G., Tzelepis, A., Koulouraki, S., Lykou, D., Metallinou, D., Erlandsson, L., Panoulis, K., Vlahos, N., Hansson, S. R., & Eleftheriades, M. (2025). The Utility of Maternal Blood S100B in Women with Suspected or Established Preeclampsia—A Systematic Review. Biomolecules. https://doi.org/10.3390/biom15060840
Vancouver
Karampas G, Tzelepis A, Koulouraki S, Lykou D, Metallinou D, Erlandsson L, et al. The Utility of Maternal Blood S100B in Women with Suspected or Established Preeclampsia—A Systematic Review. Biomolecules. 2025. doi:10.3390/biom15060840
BibTeX
@article{Karampas2025,
author = {Karampas, Grigorios and Tzelepis, Athanasios and Koulouraki, Sevasti and Lykou, Despoina and Metallinou, Dimitra and Erlandsson, Lena and Panoulis, Konstantinos and Vlahos, Nikolaos and Hansson, Stefan Rocco and Eleftheriades, Makarios},
title = {The Utility of Maternal Blood S100B in Women with Suspected or Established Preeclampsia—A Systematic Review},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15060840}
}
EUVIMED